Ryan Cohlhepp's most recent trade in Bicara Therapeutics Inc. was a trade of 17,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President, COO & Interim CEO | 08 Sep 2026 | 17,500 | 34,252 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President, COO & Interim CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 08 Sep 2026 | 17,500 | 199,141 | - | 3.8 | 66,322 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President, COO & Interim CEO | Sale of securities on an exchange or to another person at price $ 22.77 per share. | 08 Sep 2026 | 14,058 | 185,083 | - | 22.8 | 320,053 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President, COO & Interim CEO | Sale of securities on an exchange or to another person at price $ 23.43 per share. | 08 Sep 2026 | 3,442 | 181,641 | - | 23.4 | 80,663 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 27.98 per share. | 10 Aug 2026 | 18,750 | 181,641 | - | 28.0 | 524,533 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 10 Aug 2026 | 18,750 | 51,752 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 10 Aug 2026 | 18,750 | 200,391 | - | 3.8 | 71,059 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 28.76 per share. | 08 Jul 2026 | 22,833 | 187,558 | - | 28.8 | 656,652 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 08 Jul 2026 | 18,750 | 210,391 | - | 3.8 | 71,059 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 08 Jul 2026 | 18,750 | 70,502 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 29.80 per share. | 08 Jul 2026 | 4,306 | 183,252 | - | 29.8 | 128,302 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 30.36 per share. | 08 Jul 2026 | 1,075 | 182,177 | - | 30.4 | 32,632 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 08 Jul 2026 | 536 | 181,641 | - | 29 | 15,544 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 20.29 per share. | 15 May 2026 | 8,000 | 196,141 | - | 20.3 | 162,335 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 15 May 2026 | 8,000 | 101,334 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 15 May 2026 | 8,000 | 204,141 | - | 3.8 | 30,318 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 20.29 per share. | 15 May 2026 | 4,500 | 191,641 | - | 20.3 | 91,314 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 23.01 per share. | 15 Apr 2026 | 8,000 | 200,641 | - | 23.0 | 184,058 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 15 Apr 2026 | 8,000 | 109,334 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 15 Apr 2026 | 8,000 | 208,641 | - | 3.8 | 30,318 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 23.01 per share. | 15 Apr 2026 | 4,500 | 196,141 | - | 23.0 | 103,533 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 16 Mar 2026 | 8,000 | 213,141 | - | 3.8 | 30,318 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 19.66 per share. | 16 Mar 2026 | 8,000 | 205,141 | - | 19.7 | 157,257 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 16 Mar 2026 | 8,000 | 117,334 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 19.66 per share. | 16 Mar 2026 | 4,500 | 200,641 | - | 19.7 | 88,457 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 03 Mar 2026 | 12,892 | 222,533 | - | 3.8 | 48,858 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 03 Mar 2026 | 12,892 | 125,334 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.16 per share. | 03 Mar 2026 | 12,892 | 209,641 | - | 18.2 | 234,159 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.16 per share. | 03 Mar 2026 | 4,500 | 205,141 | - | 18.2 | 81,734 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.04 per share. | 25 Feb 2026 | 3,108 | 210,164 | - | 18.0 | 56,067 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 25 Feb 2026 | 3,108 | 138,226 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 25 Feb 2026 | 3,108 | 213,272 | - | 3.8 | 11,779 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.04 per share. | 25 Feb 2026 | 523 | 209,641 | - | 18.0 | 9,435 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 02 Feb 2026 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.10 per share. | 22 Jan 2026 | 3,828 | 210,164 | - | 18.1 | 69,296 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.02 per share. | 15 Jan 2026 | 149 | 213,992 | - | 18.0 | 2,685 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.44 per share. | 26 Dec 2025 | 25,000 | 214,141 | - | 4.4 | 110,923 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 26 Dec 2025 | 25,000 | 39,909 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.68 per share. | 15 Dec 2025 | 8,000 | 193,641 | - | 18.7 | 149,470 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 15 Dec 2025 | 8,000 | 141,334 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 15 Dec 2025 | 8,000 | 201,641 | - | 3.8 | 30,318 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.68 per share. | 15 Dec 2025 | 4,500 | 189,141 | - | 18.7 | 84,077 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.05 per share. | 21 Nov 2025 | 8,000 | 198,141 | - | 18.0 | 144,376 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 21 Nov 2025 | 8,000 | 206,141 | - | 3.8 | 30,318 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 21 Nov 2025 | 8,000 | 149,334 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.05 per share. | 21 Nov 2025 | 4,500 | 193,641 | - | 18.0 | 81,212 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.16 per share. | 15 Oct 2025 | 8,000 | 202,641 | - | 18.2 | 145,243 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 15 Oct 2025 | 8,000 | 210,641 | - | 3.8 | 30,318 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 15 Oct 2025 | 8,000 | 157,334 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.16 per share. | 15 Oct 2025 | 4,500 | 198,141 | - | 18.2 | 81,699 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 06 Oct 2025 | 24,000 | 245,141 | - | 3.8 | 90,955 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 06 Oct 2025 | 24,000 | 173,334 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.06 per share. | 06 Oct 2025 | 24,000 | 221,141 | - | 18.1 | 433,332 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.06 per share. | 06 Oct 2025 | 15,600 | 205,541 | - | 18.1 | 281,666 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 06 Oct 2025 | 8,000 | 165,334 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.06 per share. | 06 Oct 2025 | 8,000 | 205,541 | - | 18.1 | 144,473 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 06 Oct 2025 | 8,000 | 213,541 | - | 3.8 | 30,318 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.06 per share. | 06 Oct 2025 | 2,900 | 202,641 | - | 18.1 | 52,371 | Common Stock |